Objectives:

1. Significance of chronic kidney disease, FSGS, and race and the discovery of APOL1 and its link to hypertensive nephropathy

2. Potential clinical role of APOL1 genotyping.

Session date: 
Wednesday, September 5, 2018 - 4:00pm to 5:00pm
Speaker Name: 
Patrick Cunningham
Location: 
UCMC AMB S-534
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.